alpha-Naphthylisothiocyanate (ANIT) administration to rats results in
periportal hepatic inflammation and injury. Glutathione (GSH) appears
to be necessary for the liver injury to occur. The leukotrienes (LTs)
are metabolites of arachidonic acid and potent mediators of inflammati
on that have been implicated in certain liver injury models. Inasmuch
as GSH is a cofactor for the synthesis of cysteinyl-LTs and since infl
ammation is a prominent component of ANIT injury, we hypothesized that
LTs are involved in producing the hepatic insult that results from AN
IT administration. To test this hypothesis, rats were treated with one
of several inhibitors of LT biosynthesis, A63162, Zileuton or MK-886.
Each of these agents prevented the formation of LTB(4) in Ca++ ionoph
ore-stimulated whole blood from rats treated with the inhibitors, A631
62 attenuated the hepatic parenchymal injury caused by ANIT and result
ed in a modest decrease in ANIT-induced cholestasis. In contrast, neit
her Zileuton nor MK-886 attenuated liver injury. AT-125 (Acivicin) inh
ibits gamma-glutamyl transferase (GGT), the enzyme that catalyzes the
formation of LTD(4) from LTC(4). AT-125 pretreatment did not prevent A
NIT-induced hepatic parenchymal insult. It did, however, ameliorate th
e cholestasis caused by ANIT. In conclusion, the partial protection af
forded by A63162 and AT-125 likely results from effects unrelated to t
he formation of LTs, since Zileuton and MK-886 inhibited LT synthesis
without affording protection, The lack of protection by Zileuton and M
K-886 in the face of LT synthesis inhibition suggests that LTs are not
necessary for the expression of injury after ANIT administration.